newsfilter
← Latest News
GlobeNewswire·

OpGen Subsidiary Curetis and BioVersys Sign Collaboration Agreement for Clinical Trial Support

Unyvero platform for rapid diagnostics to be used in Phase II clinical trial of BV100Focus on the detection of pneumonia patients infected with Acinetobacter baumannii ROCKVILLE, Md. and BASEL, Switzerland, Oct. 25,